Multimodal versus narcotic pain control after rotator cuff repair
The Effect of Multimodal Pain Regimen on Use of Narcotics After Rotator Cuff Tear Repair
This trial will test whether a mostly non‑narcotic multimodal pain plan reduces opioid use and keeps patients comfortable after arthroscopic rotator cuff repair.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Enrollment | 130 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Montefiore Medical Center Academic / other |
| Locations | 1 site (The Bronx, New York) |
| Trial ID | NCT07076069 on ClinicalTrials.gov |
What this trial studies
Adults undergoing arthroscopic rotator cuff repair at Montefiore are assigned to either a previously described multimodal, primarily non‑narcotic pain protocol or the medical center's usual postoperative regimen that relies mainly on narcotics. The study measures total rescue opioid consumption after surgery along with self‑reported pain and satisfaction outcomes. Patients must be able to consent, receive a local nerve block, and tolerate the medications in the assigned regimen to participate. The investigators aim to identify a pain plan that lowers opioid use without sacrificing comfort or patient satisfaction.
Who should consider this trial
Good fit: Adults with rotator cuff tears who have failed conservative therapy and are scheduled for arthroscopic rotator cuff repair, who can consent and are eligible for a local nerve block, are ideal candidates.
Not a fit: Patients who cannot tolerate the regimen medications, have prior same‑side shoulder surgery, significant renal disease, peptic ulcer disease or GI bleeding, active substance abuse history, pregnancy, or inability to consent are unlikely to benefit from this protocol.
Why it matters
Potential benefit: If successful, this approach could allow patients to use fewer opioids after rotator cuff repair while maintaining effective pain control and satisfaction.
How similar studies have performed: Opioid‑sparing multimodal pain regimens have shown promise in other surgical populations, though direct head‑to‑head evidence specifically for arthroscopic rotator cuff repair remains limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults with rotator cuff tears who have failed conservative therapy and are now undergoing arthroscopic rotator cuff repair. Exclusion Criteria: * Patients without capacity to consent for the study * Patients not able to have local nerve block * Patients who underwent previous shoulder surgery on the same side, kindling revision rotator cuff repair * Patients who are unable to record and verbalize their pain level due to altered mental status * Patients who are unable to tolerate any of the medications included in the multimodal pain regimen or standard pain regimen due to severe allergies or inability to consume medication * Patients with history of previously diagnosed alcohol or drug abuse, renal impairment, peptic ulcer disease, and gastrointestinal bleeding * Patients who are pregnant
Where this trial is running
The Bronx, New York
- Montefiore Hutchinson Campus — The Bronx, New York, United States (Recruiting)
Study contacts
- Principal investigator: Ferdinand Chan, M.D. — Montefiore Medical Center
- Study coordinator: Ferdinand Chan, M.D.
- Email: fchan@montefiore.org
- Phone: 718-920-2060
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.